Concepedia

Angela M. Krackhardt

AM

Statistics

Publications

43

Citations

7.4K

H-Index

29

Active since

1999

Affiliations

Technical University of Munich(Current)

Klinikum rechts der Isar

German Cancer Research Center

Heidelberg University

Helmholtz Zentrum München

Angela M. Krackhardt is an author at Technical University of Munich specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

1999–2023

43

Publications

43

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial

Jeffrey S. Weber, Sandra P. D’Angelo, David R. Minor et al. · The Lancet Oncology · 2015 · 2.6K citations

, , +9

Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

David Liu, Bastian Schilling, Derek Liu et al. · Nature Medicine · 2019 · 1K citations · Full text

Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry

Michal Bassani‐Sternberg, Eva Bräunlein, Richard Klar et al. · Nature Communications · 2016 · 698 citations · Full text

Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy

Lars Hofmann, Andrea Forschner, Carmen Loquai et al. · European Journal of Cancer · 2016 · 638 citations

, , +9

Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy

Lisa Zimmer, Simone M. Goldinger, Lars Hofmann et al. · European Journal of Cancer · 2016 · 552 citations

, , +4

Rows per page

1–5 of 43